Novozymes A/S

Novozymes A/S Current Assets

The Current Assets of Novozymes A/S (NSIS B.CO) as of Oct 10, 2026 is 1.88 B EUR. In the previous year, Current Assets was 1.27 B EUR — a change of 48.30% (higher).

Current Assets

1.88 BEUR

YoY

48.30%

Last updated:

Current Assets of Novozymes A/S is 2024 1.88 B EUR. Current Assets of Novozymes A/S was 2023 1.27 B EUR. It decreases by 48.30% higher compared to the previous year.

The Novozymes A/S Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2017
6.14 B EUR
Jan 1, 2018
6.84 B EUR
Jan 1, 2019
7.05 B EUR
Jan 1, 2020
6.91 B EUR
Jan 1, 2021
1.05 B EUR
Jan 1, 2022
1.24 B EUR
Jan 1, 2023
1.27 B EUR
Jan 1, 2024
1.88 B EUR
The Novozymes A/S Current Assets history
YEARCurrent AssetsYoY
1.88 BEUR+48.30%
1.27 BEUR+2.39%
1.24 BEUR+17.97%
1.05 BEUR-84.82%
6.91 BEUR-1.97%
7.05 BEUR+3.15%
6.84 BEUR+11.37%
6.14 BEUR-4.00%
6.39 BEUR+3.99%
6.15 BEUR—
Access this data via the Eulerpool API

Novozymes A/S Stock analysis

What does Novozymes A/S do? Novozymes A/S is a leading company in the field of biocatalysis and microbial solutions. It was founded in Denmark in 1925 under the name Nordisk Insulinlaboratorium. In 2000, the company was renamed Novozymes A/S and became part of the globally operating Novo Group. Novozymes' business model is to optimize the use of biocatalysts, enzymes, and microorganisms to offer sustainable solutions for various industries. Biocatalysts are biological molecules that accelerate or enable chemical reactions. The company works closely with customers in agriculture, household, food and beverage, laundry and cleaning products, animal feed, bioenergy, and biopharmaceutical industries. Novozymes' offerings include various divisions. The largest is the enzymes division, which produces enzymes for various industries. Novozymes' enzymes are used in the food and beverage industry, pulp and paper industry, and bioenergy, among others. The microbial solutions division offers various microorganisms that can be used in the production of biogas, animal feed, or odor removal. Novozymes also has a bioagriculture division that develops solutions for sustainable agriculture. This includes disease- and pest-resistant bioseeds, as well as enhanced soil and plant care. The company also has a biopharmaceutical division that focuses on producing enzymes for disease treatment. An important goal of Novozymes is to promote sustainability and environmental protection. The company advocates for the use of renewable resources and energy-efficient processes. This is also reflected in their products, which contribute to optimizing agricultural processes and reducing greenhouse gas emissions, for example. One example of a Novozymes product is NovoGro, a biofertilizer for sustainable agriculture. NovoGro enhances nutrient uptake in plants and contributes to healthy soils. Another product is an enzyme blend called Novozyme 188, which is used in beer production to improve filtration. In summary, Novozymes A/S is a company specializing in biocatalysis and microbial solutions. The company works closely with customers from various industries to offer sustainable solutions and promote environmental protection. Novozymes has different divisions and offers solutions such as enzymes and microorganisms that can be used in the food and beverage industry, pulp and paper industry, bioenergy, biopharmaceuticals, and many other areas. With its commitment to sustainability and environmental protection, Novozymes contributes to shaping a better future. Novozymes A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Novozymes A/S stock

Current Assets of Novozymes A/S is 1.88 B EUR in 2024.

Current Assets of Novozymes A/S changed from 1.27 B EUR to 1.88 B EUR, representing a 48.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Novozymes A/S since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Novozymes A/S historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Novozymes A/S

All Key Metrics — Novozymes A/S